Mechanistic mathematical models: An underused platform for HPV research
- PMID: 28720456
- PMCID: PMC5518640
- DOI: 10.1016/j.pvr.2017.01.004
Mechanistic mathematical models: An underused platform for HPV research
Abstract
Health economic modeling has become an invaluable methodology for the design and evaluation of clinical and public health interventions against the human papillomavirus (HPV) and associated diseases. At the same time, relatively little attention has been paid to a different yet complementary class of models, namely that of mechanistic mathematical models. The primary focus of mechanistic mathematical models is to better understand the intricate biologic mechanisms and dynamics of disease. Inspired by a long and successful history of mechanistic modeling in other biomedical fields, we highlight several areas of HPV research where mechanistic models have the potential to advance the field. We argue that by building quantitative bridges between biologic mechanism and population level data, mechanistic mathematical models provide a unique platform to enable collaborations between experimentalists who collect data at different physical scales of the HPV infection process. Through such collaborations, mechanistic mathematical models can accelerate and enhance the investigation of HPV and related diseases.
Keywords: Carcinogenesis; Mathematical modeling; Mechanistic modeling; Multi-scale modeling; Natural history; Viral evolution.
Copyright © 2016 The Authors. Published by Elsevier B.V. All rights reserved.
Similar articles
-
Chapter 18: Public health policy for cervical cancer prevention: the role of decision science, economic evaluation, and mathematical modeling.Vaccine. 2006 Aug 31;24 Suppl 3:S3/155-63. doi: 10.1016/j.vaccine.2006.05.112. Vaccine. 2006. PMID: 16950003 Review.
-
Assessment and statistical modeling of the relationship between remotely sensed aerosol optical depth and PM2.5 in the eastern United States.Res Rep Health Eff Inst. 2012 May;(167):5-83; discussion 85-91. Res Rep Health Eff Inst. 2012. PMID: 22838153
-
Long-term persistence of anti-HPV-16 and -18 antibodies induced by vaccination with the AS04-adjuvanted cervical cancer vaccine: modeling of sustained antibody responses.Gynecol Oncol. 2009 Dec;115(3 Suppl):S1-6. doi: 10.1016/j.ygyno.2009.01.011. Epub 2009 Feb 12. Gynecol Oncol. 2009. PMID: 19217149
-
Mathematical models for predicting the epidemiologic and economic impact of vaccination against human papillomavirus infection and disease.Epidemiol Rev. 2006;28:88-100. doi: 10.1093/epirev/mxj006. Epub 2006 Jun 1. Epidemiol Rev. 2006. PMID: 16740585 Review.
-
Long-term efficacy of human papillomavirus vaccination.Gynecol Oncol. 2007 Nov;107(2 Suppl 1):S27-30. doi: 10.1016/j.ygyno.2007.07.078. Gynecol Oncol. 2007. PMID: 17938016 Review.
Cited by
-
Recurring infection with ecologically distinct HPV types can explain high prevalence and diversity.Proc Natl Acad Sci U S A. 2017 Dec 19;114(51):13573-13578. doi: 10.1073/pnas.1714712114. Epub 2017 Dec 5. Proc Natl Acad Sci U S A. 2017. PMID: 29208707 Free PMC article.
-
Incidence and clearance of oral and cervicogenital HPV infection: longitudinal analysis of the MHOC cohort study.BMJ Open. 2022 Jan 3;12(1):e056502. doi: 10.1136/bmjopen-2021-056502. BMJ Open. 2022. PMID: 34980629 Free PMC article.
-
Stochastic dynamics of human papillomavirus delineates cervical cancer progression.J Math Biol. 2023 Nov 12;87(6):85. doi: 10.1007/s00285-023-02018-z. J Math Biol. 2023. PMID: 37951849 Free PMC article.
-
Forecasting Disease Burden with a Dynamic Transmission Model of Human Papillomavirus and Recurrent Respiratory Papillomatosis in the United States.Viruses. 2024 Aug 11;16(8):1283. doi: 10.3390/v16081283. Viruses. 2024. PMID: 39205257 Free PMC article.
-
Patients with newly diagnosed cervical cancer should be screened for anal human papilloma virus and anal dysplasia: Results of a pilot study using a STELLA computer simulation and economic model.Papillomavirus Res. 2018 Jun;5:38-45. doi: 10.1016/j.pvr.2017.12.001. Epub 2017 Dec 13. Papillomavirus Res. 2018. PMID: 29272853 Free PMC article.
References
-
- Eddy D.M. Appropriateness of cervical cancer screening. Gynecol. Oncol. 1981;12:S168–S187. - PubMed
-
- Eddy D.M. Screening for cervical cancer. Ann. Intern Med. 1990;113:214–226. - PubMed
-
- Goldie S.J., Kim J.J., Wright T.C. Cost-effectiveness of human papillomavirus DNA testing for cervical cancer screening in women aged 30 years or more. Obstet. Gynecol. 2004;103:619–631. - PubMed
-
- Kulasingam S.L., Hughes J.P., Kiviat N.B., Mao C., Weiss N.S., Kuypers J.M. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral. JAMA. 2002;288:1749–1757. - PubMed
-
- Myers E.R., McCrory D.C., Nanda K., Bastian L., Matchar D.B. Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. Am. J. Epidemiol. 2000;151:1158–1171. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources